<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report a 36-year-old woman with the occurrence of painful <z:hpo ids='HP_0007359'>focal seizures</z:hpo> of her left hand and the left leg </plain></SENT>
<SENT sid="1" pm="."><plain>She also had <z:hpo ids='HP_0011153'>focal motor seizures</z:hpo> at the left corner of her mouth </plain></SENT>
<SENT sid="2" pm="."><plain>The duration and frequency of the episodes increased over four days from a few seconds once a day to frequent intervals lasting more than four hours at a time </plain></SENT>
<SENT sid="3" pm="."><plain>The symptoms appeared one day after start of the treatment with <z:chebi fb="0" ids="38561,38562">fluvastatin</z:chebi> (40 mg) administered in order to diminish the endothelial activation induced by <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL) </plain></SENT>
<SENT sid="4" pm="."><plain>The patient suffered from severe manifestations of the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) including Catastrophic <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid Syndrome</z:e> (CAPS, Asherson's syndrome) </plain></SENT>
<SENT sid="5" pm="."><plain>In this case a single 40 mg dose of oral <z:chebi fb="0" ids="38561,38562">fluvastatin</z:chebi> was linked to <z:hpo ids='HP_0001250'>seizures</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>After discontinuation of this treatment, the <z:hpo ids='HP_0001250'>seizures</z:hpo> immediately disappeared and the patient fully recovered without evidence of permanent neurological damage </plain></SENT>
<SENT sid="7" pm="."><plain>This data links <z:chebi fb="0" ids="35664">statins</z:chebi> to <z:hpo ids='HP_0001250'>seizures</z:hpo> in patients with compromised blood brain barrier such as APS </plain></SENT>
</text></document>